Improving The Pre-hospital Treatment And Acute Management Of Burned Children
Funder
National Health and Medical Research Council
Funding Amount
$359,942.00
Summary
Children’s burns are physically and psychologically debilitating and are a huge burden for the children themselves, their families and the Australian health care system. My work will determine exactly what conditions are required to cause burns so that we can act to prevent them. I will also develop more effective first aid treatment and new treatments to improve burn wound healing.
Development Of Monoclonal Antibody Therapy For Treating Wounds
Funder
National Health and Medical Research Council
Funding Amount
$573,354.00
Summary
Chronic wounds, diabetic ulcers, injuries in response to trauma, burns and scalds form a medical need which will only expand as the population ages and the diabetic epidemic grows. In our studies, we have shown that Flightless I (Flii), an actin-remodelling protein, is a negative regulator of wound healing. We are developing monoclonal antibodies as a new therapy for reducing Flii levels in wounds which leads to improved wound repair outcomes.
Development Of A Novel Drug For Chronic And Infected Wounds
Funder
National Health and Medical Research Council
Funding Amount
$482,362.00
Summary
Chronic wounds affect more than 9 million people worldwide and demand for wound care is increasing. The annual cost to healthcare systems in the US and Australia in treating such wounds is US$25 billion and AU$3 billion, respectively, and there is urgent need for more effective approaches.
Efficacy Of Activated Protein C To Treat Diabetic Leg Ulcers - A Randomised, Controlled Clinical Trial
Funder
National Health and Medical Research Council
Funding Amount
$519,284.00
Summary
Chronic leg ulcers are a major public health burden. Research undertaken by the CIs and funded by a NHMRC Development Grant have shown that activated protein C heals chronic wounds in animals and now in humans, and resolved mechanisms underlying activated protein C's actions. The current chronic leg ulcer trial is an essential step to validate the therapeutic use of activated protein C in wound healing, which is likely to emerge as a cost-effective treatment for this difficult health problem.
Activated Protein C Utilises Protease Activated Receptors And Epidermal Growth Factor Receptor To Heal Wounds
Funder
National Health and Medical Research Council
Funding Amount
$436,882.00
Summary
Chronic leg ulcers are a major burden to the individual sufferer and to the health system. We have discovered that activated protein C (APC) potently stimulates wound healing in the laboratory and now have exciting positive results from a small pilot clinical trial showing that applying APC solution to leg ulcers also helps healing in patients. This study plans to discover how APC works at the molecular level.
Modulating Sphingolipid Signalling To Enhance Wound Healing
Funder
National Health and Medical Research Council
Funding Amount
$698,447.00
Summary
Impaired wound healing is a major problem for diabetics, who often suffer with chronic unresolved wounds with serious effects on their quality of life and mortality. We have recently discovered a new pathway involving sphingolipids that shows great promise to improve wound healing in diabetics. In this project we will examine the targeting of this pathway, using existing and newly developed agents, to improve wound healing in advanced pre-clinical models of diabetes.
Pre-clinical Evaluation Of Nano-membrane Dressings To Promote Wound Healing
Funder
National Health and Medical Research Council
Funding Amount
$188,600.00
Summary
This project will investigate whether a novel type of wound dressing can promote faster wound healing and reduce scarring. Time taken to heal is one of the best predictors of whether a wound will heal with significant scarring. The faster wounds heal the better. We have identified a new dressing with specific nano-scale pores that may promote faster healing. This dressing will be tested in the best model of human wound healing with the potential to progress to clinical trials if successful.
The Role Of SKAM And Sphingosine Kinase In Wound Healing
Funder
National Health and Medical Research Council
Funding Amount
$281,340.00
Summary
Many aspects of wound healing are poorly understood. We have identified a novel cellular pathway that appears critically involved in controlling wound contraction. This project aims to characterise this cellular pathway to understand the exact mechanisms whereby it controls this critical aspect of wound healing. With this information we will develop topical therapeutics to aid the wound healing process.
The Role Of Flightless In The Formation Of Scar Formation And Potential As A Target For A Novel Therapy To Reduce Scarring
Funder
National Health and Medical Research Council
Funding Amount
$60,664.00
Summary
Scarring causes significant morbidity and suffering. It can lead to pain, disfigurement and impaired physical function, which require costly ongoing care. Flightless (Flii) is a novel protein, which acts as a negative regulator of wound healing. Flii neutralising antibody treatment has been shown to improve wound healing. However, the role of Flii in scarring has yet to be investigated. This project will investigate the role of Flii in scarring and its potential as a therapeutic target.
Wounds and burn injuries are frequent injuries which can lead to deformity, disfigurement and loss of movement. The cytoskeleton is integral to the wound healing process and we have shown that a specific cytoskeletal protein, Flightless I (Flii), is an important regulator of wound repair. During the course of this fellowship I plan to further my investigations into the function and regulation of Flii in wounds and aim to develop new therapies for treating wounds and reducing scar formation.